Findings

What do systematic reviews say?

427 questions · 437 findings · 29 reviews · Schizophrenia

Sort:Best matchNewest Highest certainty Download CSV

No studies found 77 · 17.6%GRADE not reported 61 · 14%Very low 130 · 29.7%Low 103 · 23.6%Moderate 54 · 12.4%High 12 · 2.7%

Atypical (standard‐dose) vs atypical (low‐dose) antipsychotics (only short term)

Weight gain · people with psychosis

1 finding from 1 review

Atypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 257 participants
High

Atypical vs typical antipsychotics (only short term)

Worse or no improvement · people with psychosis

1 finding from 1 review

Atypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 21 participants
Low

Atypical vs typical antipsychotics (only short term)

Adverse effects ‐ anticholinergic effects · people with psychosis

1 finding from 1 review

Atypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 40 participants
Moderate

Atypical vs typical antipsychotics (only short term)

Drop in the absolute neutrophil count below 1500 per mm3 · people with psychosis

1 finding from 1 review

Atypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 21 participants
Very low

Atypical vs typical antipsychotics (only short term)

Adverse effects: Leaving the study early · people with psychosis

1 finding from 1 review

Atypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes only
no estimate extracted
1 study · 21 participants
Moderate

Atypical vs atypical antipsychotics (only short term)

No improvement (risperidone vs olanzapine) · people with psychosis

1 finding from 1 review

Atypical antipsychotics for psychosis in adolescents 2013 · Cochrane Headline outcomes only
no estimate extracted
2 studies · 111 participants
Moderate

ECT plus standard care vs antipsychotics plus standard care

Satisfaction with treatment: leaving the study early Endpoint data (events) · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ECT plus standard care vs antipsychotics plus standard care

Mental state · people with treatment‐resistant schizophrenia

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 162 participants
Very low

ECT plus standard care vs antipsychotics plus standard care

Functioning: clinically important change in general functioning, as defined by individual studies · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ECT plus standard care vs antipsychotics plus standard care

Service outcomes: Hospitalisation · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ECT plus standard care vs antipsychotics plus standard care

Adverse event/effect(s) ‐ death · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ECT alone vs antipsychotics

Response to treatment Clinically significant response to treatment as defined by each study · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ECT alone vs antipsychotics

Cognitive functioning Clinically important change in cognitive functioning as defined by each study · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ECT alone vs antipsychotics

Satisfaction with treatment: leaving the study early Endpoint data (events) · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ECT alone vs antipsychotics

Mental state · people with treatment‐resistant schizophrenia

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

ECT alone vs antipsychotics

General functioning: Average endpoint general functioning score (clinically improved) (no data) · people with treatment‐resistant schizophrenia

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
1 study · 30 participants
Very low

ECT alone vs antipsychotics

Service outcomes: Hospitalisation · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ECT alone vs antipsychotics

Adverse event/effect(s) ‐ death · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found

ECT plus standard care vs antipsychotics plus standard care

Response to treatment (medium term) Clinically important response to treatment as defined by each study · people with treatment‐resistant schizophrenia

ECT plus standard care showed no clear difference in response to treatment (medium term) Clinically important response to… compared with antipsychotics plus standard care (low certainty).

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
RR 1.23 [0.95, 1.58]
1 study · 162 participants
Low

ECT plus standard care vs antipsychotics plus standard care

Cognitive functioning Clinically important change in cognitive functioning as defined by each study · people with treatment‐resistant schizophrenia

The review found no eligible studies for this question.

1 finding from 1 review

Electroconvulsive therapy for treatment‐resistant schizophrenia 2019 · Cochrane Headline outcomes only
no estimate extracted
Studies not reported
No studies found